Operating Room With AI-Integrated Biplane Angiograph Opens in Tyumen
On June 30, 2025, a groundbreaking hybrid operating room featuring the first AI-integrated biplane angiograph in Russia began operations at the Federal Center for Neurosurgery (FCN) in Tyumen. The installation marks a significant leap in high-tech medical capabilities within the country.
AI in the Operating Room
The Federal Center for Neurosurgery in Tyumen is a cornerstone of neurosurgical care in Russia, serving patients nationwide. The newly launched operating room is equipped with a next-generation biplane angiograph that enables simultaneous dual-plane scanning. It integrates real-time CT and MRI imaging, displays 3D vascular and tissue visuals, reduces radiation exposure, and minimizes contrast agent usage. Importantly, it significantly shortens surgical durations—from several hours to just 20–30 minutes. Integrated AI analyzes imaging data during surgery, offering predictions on procedural outcomes in real time. This translates into more precise, safer, and quicker brain and vascular surgeries, expanding access to advanced care for thousands of Russian patients.
A National Milestone
The new facility will be used for complex procedures such as aneurysms, arteriovenous malformations, deep brain and spinal tumors, and facial cranial pathologies. These operations require precision and speed, and the AI-assisted angiograph provides a critical edge. This is not merely a case of equipment import—it reflects a systemic integration of world-class techniques into Russian clinical practice. Though manufactured abroad, the angiograph’s successful implementation signifies Russia’s growing maturity in applying high-level medical technologies. Early surgeries have already been performed, with a broader rollout of complex interventions anticipated in the coming months.
Scaling Innovation
The new operating room sets a precedent for medical innovation across Russia. FCN in Tyumen has long been a hub of technological adoption, having implemented a hybrid CT operating suite in 2015 and added high-end MRI scanners, intraoperative O-arm navigation, and SonoWand neuronavigation between 2021 and 2023. The arrival of the biplane angiograph in April 2025 continues this trajectory. The facility’s opening was widely covered in federal media, establishing Tyumen’s FCN as a national leader in neuro-medicine. Similar operating rooms could be replicated in other major cities, fostering an interconnected network of advanced neurosurgical centers.
Toward Technological Sovereignty
The system’s high demand and performance underscore the need for domestic development. Its success is expected to drive R&D in medical technology, software development, and healthcare digital platforms. Tyumen’s experience could inspire the creation of Russian-manufactured equivalents for broader export and adoption. The AI-integrated suite represents a cornerstone in building Russia’s technological sovereignty. It has the potential to scale into domestic production, international tenders, and greater global recognition of Russian medical innovation.
A National Health Strategy
This initiative aligns with national programs such as “Active and Healthy Longevity” and “New Health Preservation Technologies.” It not only saves lives but also symbolizes Russia’s path from import dependence to strategic independence and cohesive healthcare excellence. Tyumen demonstrates that Russia is not just adapting to global healthcare trends—it is actively shaping them.
Expert Insight
